Related Experiment Video
Updated: Jul 7, 2025
Evaluating Cell Death Signaling by Immunofluorescence in a Rat Model of Ischemic Stroke
Published on: January 3, 2025
AIM2 inflammasome: A potential therapeutic target in ischemic stroke
Rong Fu1, Linna Zhao2, Yuying Guo2
1First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China; National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China; Tianjin University of Traditional Chinese Medicine, Tianjin, China.
The Absent in Melanoma 2 (AIM2) inflammasome plays a key role in brain inflammation after ischemic stroke. Targeting this inflammasome offers a potential new therapeutic strategy for stroke treatment.
Area of Science:
- Neuroscience
- Immunology
- Molecular Biology
Background:
- Ischemic stroke (IS) is a major cause of death and disability worldwide.
- Inflammation is a critical component of brain injury following IS.
- Inflammasomes, like AIM2, are key regulators of inflammatory responses.
Purpose of the Study:
- To summarize the role of the AIM2 inflammasome in ischemic brain injury.
- To review the expression and regulation of AIM2 in the central nervous system (CNS) and peripheral immune cells.
- To discuss potential therapeutic strategies targeting the AIM2 inflammasome.
Main Methods:
- Literature review of studies on AIM2 inflammasome in ischemic stroke.
- Analysis of AIM2 expression and function in CNS and peripheral immune cells.
- Discussion of current and emerging therapeutic approaches.
Main Results:
- Aberrant AIM2 inflammasome expression is linked to ischemic brain injury pathology.
- AIM2 detects DNA, initiating inflammatory responses relevant to stroke.
- AIM2 is expressed in both CNS and peripheral immune cells involved in stroke.
Conclusions:
- The AIM2 inflammasome is a significant contributor to the inflammatory processes in ischemic stroke.
- Targeting the AIM2 inflammasome presents a promising avenue for novel stroke therapies.
- Further research is needed to fully elucidate AIM2's role and therapeutic potential.
